The role of carbohydrate chains in vaccine development is pivotal, as they influence immune responses and antigen stability. Glycosylation patterns on glycoproteins can enhance immunogenicity and provide specificity for target pathogens. Understanding and optimizing carbohydrate structures enable the design of more effective and targeted vaccines, improving protection against infectious diseases and advancing immunotherapy strategies.